|
Market Closed -
Nasdaq
06:00:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.820 USD | 0.00% |
|
+1.39% | +58.26% |
| Market Cap | 810M 720M 672M 612M 1.15B 77.85B 1.17B 8.13B 3.15B 39.8B 3.04B 2.97B 128B | P/E 2026 * |
-10.7x | P/E 2027 * | -9.1x |
|---|---|---|---|---|---|
| Enterprise Value | 810M 720M 672M 612M 1.15B 77.85B 1.17B 8.13B 3.15B 39.8B 3.04B 2.97B 128B | EV / Sales 2026 * |
21.8x | EV / Sales 2027 * | 47.8x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 week | +1.39% | ||
| Current month | -2.93% | ||
| 1 month | -19.47% | ||
| 3 months | -21.55% | ||
| 6 months | +14.47% | ||
| Current year | +58.26% |
| 1 week | 1.8 |  | 2.05 |
| 1 month | 1.76 | | 2.25 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% | ||
| 3/6/26 | Exercice | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.39% | +29.08% | +75.00% | 810M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.20% | -0.39% | +50.28% | +123.19% | 39.13B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.90% | +138.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.17M 33.02M 30.82M 28.09M 52.98M 3.57B 53.47M 373M 145M 1.83B 140M 137M 5.86B | 16.93M 15.05M 14.04M 12.8M 24.14M 1.63B 24.37M 170M 65.85M 832M 63.58M 62.2M 2.67B |
| Net income | -73.77M -65.54M -61.17M -55.76M -105M -7.09B -106M -740M -287M -3.63B -277M -271M -11.63B | -97.05M -86.23M -80.48M -73.36M -138M -9.33B -140M -974M -377M -4.77B -364M -356M -15.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | USD 1.820 | 0.00% | 2,317,716 |
| 01/10/26 | USD 1.820 | -2.93% | 2,273,032 |
| 30/09/26 | USD 1.875 | -0.27% | 1,744,199 |
| 29/09/26 | USD 1.880 | -1.05% | 3,946,250 |
| 28/09/26 | USD 1.900 | +5.85% | 10,893,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
